Search research articles
Contact Us
Filters
Showing results (1-10 of 68) with videos related to
Page
of 7
Sort By:
The Medico-Legal Journal
|
March 6, 2003
The culture of the accident
Peter Marks
Clinical Medicine (London, England)
|
March 6, 2003
The evolution of the doctrine of consent
Peter Marks
The New England Journal of Medicine
|
October 8, 2025
Restoring Confidence in Public Health
Peter Marks
The New England Journal of Medicine
|
June 25, 2025
The Role of Public Health Agencies in Creating Vaccine Policy
Peter Marks
Mayo Clinic Proceedings
|
October 3, 2024
Defining the Rates of Rare COVID-19 Vaccine-Related Adverse Events
Peter Marks
Expert Opinion on Biological Therapy
|
March 31, 2022
Enhancing gene therapy regulatory interactions
Peter Marks
The New England Journal of Medicine
|
May 15, 2025
Progress in the Development of N-of-1 Therapy
Peter Marks
Clinical and Translational Science
|
July 23, 2019
The FDA's Regulatory Framework for Chimeric Antigen Receptor-T Cell Therapies
Peter Marks
Nature Medicine
|
October 29, 2021
What regulators must learn from COVID-19
Peter Marks
Clinical Medicine (London, England)
|
September 22, 2007
Alcohol-related road traffic accidents: promoting a lower alcohol strategy
Peter Marks, Roger Williams
Page
of 7
Search research articles
Search
Showing results (1-10 of 68) with videos related to
Sort By:
Page
of 7
The Medico-Legal Journal
|
March 6, 2003
The culture of the accident
Peter Marks
Clinical Medicine (London, England)
|
March 6, 2003
The evolution of the doctrine of consent
Peter Marks
The New England Journal of Medicine
|
October 8, 2025
Restoring Confidence in Public Health
Peter Marks
The New England Journal of Medicine
|
June 25, 2025
The Role of Public Health Agencies in Creating Vaccine Policy
Peter Marks
Mayo Clinic Proceedings
|
October 3, 2024
Defining the Rates of Rare COVID-19 Vaccine-Related Adverse Events
Peter Marks
Expert Opinion on Biological Therapy
|
March 31, 2022
Enhancing gene therapy regulatory interactions
Peter Marks
The New England Journal of Medicine
|
May 15, 2025
Progress in the Development of N-of-1 Therapy
Peter Marks
Clinical and Translational Science
|
July 23, 2019
The FDA's Regulatory Framework for Chimeric Antigen Receptor-T Cell Therapies
Peter Marks
Nature Medicine
|
October 29, 2021
What regulators must learn from COVID-19
Peter Marks
Clinical Medicine (London, England)
|
September 22, 2007
Alcohol-related road traffic accidents: promoting a lower alcohol strategy
Peter Marks, Roger Williams
Page
of 7